Gout Trial, Recruiting NCT07613138 Sponsor: Beijing Zhecheng Biotechnology Co., Ltd. Condition: Gout
Back to Gout

Gout Trial, Recruiting

NCT07613138
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 65 years old (any sex)
  • You have been diagnosed with high uric acid levels in your blood (called primary hyperuricemia), with levels in a specific range — either 420–540 μmol/L if you have no other health conditions, or 420–480 μmol/L if you also have at least one of the following: high blood pressure, high cholesterol or fats in the blood, diabetes, obesity, stroke, coronary heart disease, heart failure, or moderate-to-advanced kidney disease (confirm with trial site)
  • You have high uric acid levels but have never had a gout attack and have never taken medication to lower uric acid
  • You are willing to take part voluntarily and sign a consent form

Who may not be able to join:

  • You have a known allergy or sensitivity to any of the study medications, foods, or their ingredients
  • You have active liver disease, liver scarring (cirrhosis), or certain abnormal liver test results
  • You currently have an active infection or active stomach/intestinal ulcers
  • You have a history of thyroid problems
  • Your kidneys are not working well enough, based on a specific kidney function test result (confirm with trial site)
  • You have serious heart problems, such as severe heart failure, unstable chest pain, or a heart attack in the past 12 months
  • You have certain kidney structural problems, such as kidney cysts or blockages in the urinary tract
  • You have rheumatoid arthritis requiring treatment, or joint disease from another cause
  • You are currently taking certain medicines that affect uric acid levels — a long list of specific drugs is included, so check with the trial site if you are unsure about your current medications
  • Your high uric acid levels are caused by a blood disorder, kidney disease, or cancer treatment (such as radiotherapy or chemotherapy)
  • You have a brain condition or mental health condition that affects your ability to cooperate with the study
  • You have problems with alcohol or substance use
  • You have taken part in another clinical trial in the last 3 months
  • You have cancer or active tuberculosis
  • You are currently taking steroid medications (glucocorticoids)
  • You have any other condition that the trial doctor believes could affect the results or your ability to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86 010 64935208

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Zhecheng Biotechnology Co., Ltd.
Registry
ClinicalTrials.gov
Start date
4 June 2026
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Difference in serum urate (sUA) levels between groups at week 24

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov